Fallopian Tube High Grade Serous Adenocarcinoma

general

A rapidly growing serous adenocarcinoma that arises from the fallopian tube. It is characterized by the presence of high-grade cytologic features and frequent mitotic figures.

74

Centers

224

Active Trials

$876M

Cancer Funding

Specific Cancer Types(3)

Top Centers for Fallopian Tube High Grade Serous Adenocarcinoma(74)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.9
271.9
3
NCI Comprehensive
High-Volume Research Center
71.9
4
NCI Comprehensive
Active Research Program
69.4
5
NCI Comprehensive
Active Research Program
69.4
6
Active Research Program
69.4
7
Active Research Program
69.4
8
Active Research Program
69.4
9
Active Research Program
69.4
10
NCI Comprehensive
Active Research Program
64.8
11
NCI Comprehensive
Active Research Program
64.8
12
NCI Comprehensive
Active Research Program
64.8
13
NCI Comprehensive
Active Research Program
64.8
14
NCI Comprehensive
Active Research Program
64.8
15
NCI Comprehensive
Active Research Program
64.8
16
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
64.8
17
NCI Comprehensive
Active Research Program
64.8
18
Active Research Program
64.8
19
NCI Comprehensive
Active Research Program
53.2
20
NCI Comprehensive
Active Research Program
53.2
21
NCI Comprehensive
Active Research Program
53.2
22
NCI Comprehensive
Active Research Program
53.2
23
NCI Comprehensive
Active Research Program
53.2
24
NCI Comprehensive
Active Research Program
53.2
25
NCI Comprehensive
Active Research Program
53.2
26
NCI Comprehensive
Active Research Program
53.2
27
NCI Comprehensive
Active Research Program
53.2
28
NCI Comprehensive
Active Research Program
53.2
29
NCI Comprehensive
Active Research Program
53.2
30
NCI Comprehensive
Active Research Program
53.2
31
NCI Comprehensive
Active Research Program
53.2
32
NCI Comprehensive
Active Research Program
53.2
33
NCI Clinical
Active Research Program
53.2
34
NCI Comprehensive
Active Research Program
53.2
35
NCI Comprehensive
Active Research Program
53.2
36
NCI Clinical
Active Research Program
53.2
37
NCI Comprehensive
Active Research Program
53.2
38
NCI Clinical
Active Research Program
53.2
39
Active Research Program
53.2
40
NCI Comprehensive
Active Research Program
53.2
4153.2
42
Active Research Program
53.2
43
Active Research Program
53.2
4453.2
45
Active Research Program
53.2
46
Active Research Program
53.2
47
NCI Comprehensive
Active Research Program
36.6
48
NCI Comprehensive
Active Research Program
36.6
49
NCI Comprehensive
Active Research Program
36.6
50
NCI Comprehensive
Active Research Program
36.6
51
NCI Comprehensive
Active Research Program
36.6
52
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
36.6
53
NCI Comprehensive
Active Research Program
36.6
54
NCI Comprehensive
Active Research Program
36.6
55
NCI Comprehensive
Active Research Program
36.6
56
NCI Clinical
Active Research Program
36.6
57
NCI Comprehensive
Active Research Program
36.6
58
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
36.6
59
Active Research Program
36.6
60
NCI Clinical
Active Research Program
36.6
61
NCI Comprehensive
Active Research Program
36.6
62
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
36.6
63
Active Research Program
36.6
64
NCI Basic_laboratory
Active Research Program
36.6
65
Active Research Program
36.6
66
Active Research Program
36.6
67
Active Research Program
36.6
68
Active Research Program
36.6
69
Active Research Program
36.6
70
Active Research Program
36.6
71
Active Research Program
36.6
72
NCI Comprehensive
28.5
73
NCI Comprehensive
74
NCI Comprehensive

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →